August 5, 2011
PharmaTimes By Lynne Taylor To feel comfortable with generic biologics (biosimilars), US payers are likely to require more clinical information than what might be accepted by the Food and Drug Administration (FDA) for approvals, a new report suggests. For example, FDA approval of biosimilar versions of monoclonal antibodies (MAbs) for oncology indications will not allay […]
August 4, 2011
Developing the Nation’s Biosimilars Program Steven Kozlowski, M.D., Janet Woodcock, M.D., Karen Midthun, M.D., and Rachel Behrman Sherman, M.D., M.P.H. New England Journal of Medicine August 4, 2011 Biologic products developed over the past three decades and approved by the Food and Drug Administration (FDA) now provide important therapeutic options for a variety of serious […]
August 3, 2011
Reuters By Anna Yukhananov Evaluating generic versions of complex biotechnology medicines will require a new, more rigorous review process, U.S. drug regulators said, in the first glimpse of their thinking on the subject. Drugmakers, investors and others have been clamoring for more insight into the approval process for cheaper versions of biotech drugs, known as […]
August 1, 2011
By Helena R. Berger, Executive Vice President & CEO, American Association of People with Disabilities Buffalo News The future of medicine is biologic drugs. Not only have they revolutionized the medical treatments of serious diseases, they have also transformed treatments for many people with disabilities – from offering new promise to people with multiple sclerosis […]
August 1, 2011
Alliance for Safe Biologic Medicines & Pennsylvania Bio August 17, 2011 The Quorum at the University Science Center Philadelphia, PA Read More
July 28, 2011
Orange County Register By Thair Phillips, President, RetireSafe The biotech revolution has brought hope to millions of Americans coping with some of the most devastating medical conditions, including cancer, Parkinson’s disease and rheumatoid arthritis. New prescription drugs, known as biologics, that were born of this revolution now comprise the fastest-growing segment of the pharmaceutical market […]
July 14, 2011
September 20, 2011 Rice Hotel Houston, TX Read More
July 14, 2011
June 21, 2011 Trevisio Restaurant – 6550 Bertner Street Houston, TX Read More
July 14, 2011
BioDFW BioHouston BioMed – San Antonio Health Industry Council of North Texas Houston Technology Center San Antonio Life Sciences Association Texas A&M Health Science Center Texas Bioscience Institute Texas Department of State Health Services Texas Emerging Technology Fund Texas Healthcare & Bioscience Institute Texas House of Representatives Texas Life Science Center Texas Life Sciences Collaboration […]
